The therapeutic effect of treatment of epilepsy is limited by the development of multidrug resistance, which mainly induced by intrinsic or acquired overexpression of efflux pumps in the blood–brain barrier (BBB), such as P-glycoprotein and multidrug-resistance associated protein 1 (MRP1) [3]. Here, ABCC1 is linked to epilepsy.